Pre-existing antibody levels negatively correlate with antibody titers after a single dose of BBV152 vaccination

por Das, Suman, Singh, Janmejay, Shaman, Heena, Singh, Balwant, Anantharaj, Anbalagan, Sharanabasava, Patil, Pandey, Rajesh, Lodha, Rakesh, Pandey, Anil Kumar, Medigeshi, Guruprasad R.
Publicado 2022

BA.1, BA.2 and BA.2.75 variants show comparable replication kinetics, reduced impact on epithelial barrier and elicit cross-neutralizing antibodies

por Singh, Janmejay, Anantharaj, Anbalagan, Panwar, Aleksha, Rani, Chitra, Bhardwaj, Monika, Kumar, Parveen, Chattopadhyay, Partha, Devi, Priti, Maurya, Ranjeet, Mishra, Pallavi, Pandey, Anil Kumar, Pandey, Rajesh, Medigeshi, Guruprasad R.
Publicado 2023

Evaluation of safety and immunogenicity of receptor-binding domain-based COVID-19 vaccine (Corbevax) to select the optimum formulation in open-label, multicentre, and randomised ph...

por Thuluva, Subhash, Paradkar, Vikram, Gunneri, Subba Reddy, Yerroju, Vijay, Mogulla, Rammohan, Turaga, Kishore, Kyasani, Mahesh, Manoharan, Senthil Kumar, Medigeshi, Guruprasad, Singh, Janmejay, Shaman, Heena, Singh, Chandramani, Rao A, Venkateshwar
Publicado 2022

Omicron sub-lineage BA.5 infection results in attenuated pathology in hACE2 transgenic mice

por Rizvi, Zaigham Abbas, Dandotiya, Jyotsna, Sadhu, Srikanth, Khatri, Ritika, Singh, Janmejay, Singh, Virendra, Adhikari, Neeta, Sharma, Kritika, Das, Vinayake, Pandey, Amit Kumar, Das, Bhabatosh, Medigeshi, Guruprasad, Mani, Shalendra, Bhatnagar, Shinjini, Samal, Sweety, Pandey, Anil Kumar, Garg, Pramod Kumar, Awasthi, Amit
Publicado 2023

Sub-optimal neutralisation of omicron (B.1.1.529) variant by antibodies induced by vaccine alone or SARS-CoV-2 Infection plus vaccine (hybrid immunity) post 6-months

por Medigeshi, Guruprasad R, Batra, Gaurav, Murugesan, Deepika Rathna, Thiruvengadam, Ramachandran, Chattopadhyay, Souvick, Das, Bhabatosh, Gosain, Mudita, Ayushi, Singh, Janmejay, Anbalagan, Anantharaj, Shaman, Heena, Pargai, Kamal, Mehdi, Farha, Das, Soon Jyoti, Kahlon, Namrata, Singh, Savita, Kshetrapal, Pallavi, Wadhwa, Nitya, Pandey, Anil K, Bhatnagar, Shinjini, Garg, Pramod Kumar
Publicado 2022

Immunogenicity and safety of Biological E’s CORBEVAX™ vaccine compared to COVISHIELD™ (ChAdOx1 nCoV-19) vaccine studied in a phase-3, single blind, multicentre, randomized clinical...

por Thuluva, Subhash, Paradkar, Vikram, Gunneri, SubbaReddy, Yerroju, Vijay, Mogulla, Rammohan, Suneetha, Pothakamuri Venkata, Turaga, Kishore, Kyasani, Mahesh, Manoharan, Senthil Kumar, Adabala, Srikanth, Sri Javvadi, Aditya, Medigeshi, Guruprasad, Singh, Janmejay, Shaman, Heena, Binayke, Akshay, Zaheer, Aymaan, Awasthi, Amit, Singh, Chandramani, Rao A, Venkateshwar, Basu, Indranil, Kumar, Khobragade Akash Ashok, Pandey, Anil Kumar
Publicado 2023

Ancestral SARS-CoV-2-Driven Antibody Repertoire Diversity in an Unvaccinated Individual Correlates with Expanded Neutralization Breadth

por Deshpande, Suprit, Ansari, Mohammed Yousuf, Sutar, Jyoti, Das, Payel, Hingankar, Nitin, Mukherjee, Sohini, Jayal, Priyanka, Singh, Savita, Anantharaj, Anbalagan, Singh, Janmejay, Chattopadhyay, Souvick, Raghavan, Sreevatsan, Gosain, Mudita, Chauhan, Supriya, Shrivas, Shweta, Prasad, Chaman, Chauhan, Sangeeta, Sharma, Neha, Jana, Pradipta, Thiruvengadam, Ramachandran, Kshetrapal, Pallavi, Wadhwa, Nitya, Das, Bhabatosh, Batra, Gaurav, Medigeshi, Guruprasad, Sok, Devin, Bhatnagar, Shinjini, Garg, Pramod Kumar, Bhattacharya, Jayanta
Publicado 2023

A combination of potently neutralizing monoclonal antibodies isolated from an Indian convalescent donor protects against the SARS-CoV-2 Delta variant

por Hingankar, Nitin, Deshpande, Suprit, Das, Payel, Rizvi, Zaigham Abbas, Wibmer, Constantinos Kurt, Mashilo, Poppy, Ansari, Mohammed Yousuf, Burns, Alison, Barman, Shawn, Zhao, Fangzhu, Mukherjee, Sohini, Torres, Jonathan L., Chattopadhyay, Souvick, Mehdi, Farha, Sutar, Jyoti, Rathore, Deepak Kumar, Pargai, Kamal, Singh, Janmejay, Sonar, Sudipta, Jakhar, Kamini, Dandotiya, Jyotsna, Bhattacharyya, Sankar, Mani, Shailendra, Samal, Sweety, Singh, Savita, Kshetrapal, Pallavi, Thiruvengadam, Ramachandran, Batra, Gaurav, Medigeshi, Guruprasad, Ward, Andrew B., Bhatnagar, Shinjini, Awasthi, Amit, Sok, Devin, Bhattacharya, Jayanta
Publicado 2022

A broadly neutralizing monoclonal antibody overcomes the mutational landscape of emerging SARS-CoV-2 variants of concern

por Parray, Hilal Ahmad, Narayanan, Naveen, Garg, Sonal, Rizvi, Zaigham Abbas, Shrivastava, Tripti, Kushwaha, Sachin, Singh, Janmejay, Murugavelu, Praveenkumar, Anantharaj, Anbalagan, Mehdi, Farha, Raj, Nisha, Singh, Shivam, Dandotiya, Jyotsna, Lukose, Asha, Jamwal, Deepti, Kumar, Sandeep, Chiranjivi, Adarsh K., Dhyani, Samridhi, Mishra, Nitesh, Kumar, Sanjeev, Jakhar, Kamini, Sonar, Sudipta, Panchal, Anil Kumar, Tripathy, Manas Ranjan, Chowdhury, Shirlie Roy, Ahmed, Shubbir, Samal, Sweety, Mani, Shailendra, Bhattacharyya, Sankar, Das, Supratik, Sinha, Subrata, Luthra, Kalpana, Batra, Gaurav, Sehgal, Devinder, Medigeshi, Guruprasad R., Sharma, Chandresh, Awasthi, Amit, Garg, Pramod Kumar, Nair, Deepak T., Kumar, Rajesh
Publicado 2022